Not just digital pathology, intelligent digital pathology

JAMA Oncology

Volumn 4, Issue 3, 2018, Pages 403-404

  Acs, Balazs ^a   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIGITAL IMAGING; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LEARNING ALGORITHM; LYMPH NODE METASTASIS; NETHERLANDS; SIMULATION; ALGORITHM; BREAST TUMOR; IMAGE PROCESSING; LYMPH NODE;

ALGORITHMS; BREAST NEOPLASMS; DEEP LEARNING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODES;

EID: 85047445061     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2017.5449     Document Type: Article

References (7)

1. Bejnordi BE, Veta M, van Diest PJ, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA. 2017;318(22):2199-2210.
2. Wang X, Janowczyk A, Zhou Y, et al. Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images. Sci Rep. 2017;7(1):13543.
3. Romo-Bucheli D, Janowczyk A, Gilmore H, Romero E, Madabhushi A. Automated tubule nuclei quantification and correlation with oncotype DX risk categories in ER+ breast cancer whole slide images. Sci Rep. 2016;6:32706.
4. Lee G, Sparks R, Ali S, et al. Co-occurring gland angularity in localized subgraphs. PLoS One. 2014;9 (5):e97954.
5. Mittendorf EA, Ballman KV, McCall LM, et al. Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer. J Clin Oncol. 2015;33(10): 1119-1127.
6. Mukhopadhyay S, Feldman MD, Abels E, et al. Whole slide imaging versus microscopy for primary diagnosis in surgical pathology [published online September 28, 2017]. Am J Surg Pathol. doi:10.1097 /PAS.0000000000000948
7. US Food and Drug Administration. FDA approves tisagenlecleucel for B-cell ALL and tocilizumab for cytokine release syndrome. FDA. 2017; https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm574154.htm.